Targeting Mitochondria 2022 Best Poster Presentation Awards
The #WorldMitochondriaSociety Scientific Committee awarded three poster presenters for the insightful research and strategic results that they presented during Targeting Mitochondria 2022. We will be looking forward to learning about their progress during the next edition.
 |
Peptide Mediated Mitochondrial Delivery of Temozolomide for Evading Cellular Resistance Mechanism Daniel Szames commented: "Future work involving mitochondria-targeted temozolomide include further exploring the therapeutic potential as well as exploring its use as a DNA-damage repair probe. The use of patient-derived glioblastoma stem cells will act as a relevant model to determine whether mitochondria-targeted temozolomide has clinical potential. This compound can also be used to investigate the role of other DNA-damage repair mechanisms in mitochondria; for example, to investigate the role of mismatch repair in mitochondria." |
 |
Mitochondrial Genomes Long Read Sequencing Methodology Applied to Multispecies for the Identification of Genetic Variants Sophie Dhorne-Pollet, Université Paris-Saclay, INRAE, France |
 |
Mitochondria Enriched NK Cell Therapy for Solid Tumors |
If you wish to review these posters, you can order the abstracts here.
Targeting Mitochondria 2022 Congress
October 26-28, 2022 - Berlin, Germany
wms-site.com
